Schedule 13G ownership disclosure

PYXIS ONCOLOGY INC

Common Stock, par value $0.001 per share · CUSIP: 747324101

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Ridgeback Capital Investments L.P.

    Shares: 359,231.00 · Class: 0.6%

  • Ridgeback Capital Investments LLC

    Shares: 359,231.00 · Class: 0.6%

  • Ridgeback Capital Management LLC

    Shares: 359,231.00 · Class: 0.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014027
Form type
SCHEDULE 13G/A
Filer
Pyxis Oncology, Inc.
CIK
CIK 1782223
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub